Ginkgo Bioworks Holdings EPS - Earnings per Share 2020-2023 | DNA
Ginkgo Bioworks Holdings eps - earnings per share from 2020 to 2023. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Ginkgo Bioworks Holdings Annual EPS |
| 2022 |
$-1.25 |
| 2021 |
$-1.39 |
| 2020 |
$-0.10 |
| 2019 |
$-0.10 |
| Ginkgo Bioworks Holdings Quarterly EPS |
| 2023-03-31 |
$-0.11 |
| 2022-12-31 |
$-0.06 |
| 2022-09-30 |
$-0.41 |
| 2022-06-30 |
$-0.41 |
| 2022-03-31 |
$-0.37 |
| 2021-12-31 |
$-1.21 |
| 2021-09-30 |
$-0.08 |
| 2021-06-30 |
$-0.04 |
| 2021-03-31 |
$-0.06 |
| 2020-12-31 |
$0.00 |
| 2020-09-30 |
$-0.02 |
| 2019-12-31 |
$0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$3.379B |
$0.478B |
|
Ginkgo Bioworks platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks, formerly known as Soaring Eagle Acquisition Corp., is based in NEW YORK.
|
